SCHEMBL8316809

SCHEMBL8316809

CC(C)(C)OC(=O)CS(=O)(=O)c1cccs1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.42
NPC1 O15118 3/20 0.42
MMP1 P03956 1/20 0.41
MMP9 P14780 1/20 0.41
MMP13 P45452 1/20 0.41
ALDH1A1 P00352 4/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
MAPK1 P28482 1/20 0.40
HSD17B10 Q99714 1/20 0.40
PKM P14618 1/20 0.39
F2 P00734 1/20 0.39
PRSS1 P07477 1/20 0.39
PRSS2 P07478 1/20 0.39
PRSS3 P35030 1/20 0.39
MAPT P10636 3/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13299611 0.80 KMT2A (0.53) RAB9ANPC1ALDH1A1SMN1; SMN2MEN1
SCHEMBL13299630 0.79 MAPT (0.44) RAB9ANPC1ALDH1A1SMN1; SMN2MEN1
SCHEMBL6206228 0.75 TSHR (0.51) RAB9ANPC1MMP1MMP9MMP13
SCHEMBL8312489 0.75 CA2 (0.34) RAB9AALDH1A1KMT2AHSD17B10PKM
SCHEMBL1478276 0.74 F2 (0.51) RAB9ANPC1ALDH1A1SMN1; SMN2MEN1
SCHEMBL10916089 0.71 NPC1 (0.49) RAB9ANPC1ALDH1A1SMN1; SMN2MEN1
SCHEMBL878312 0.70 CYP2D6 (0.53) RAB9ANPC1ALDH1A1SMN1; SMN2HSD17B10
SCHEMBL28399625 0.70 RECQL (0.51) RAB9ANPC1ALDH1A1TSHR
SCHEMBL13299619 0.70 PKM (0.48) RAB9ANPC1ALDH1A1SMN1; SMN2MEN1
SCHEMBL5464840 0.69 F2 (0.50) RAB9ANPC1ALDH1A1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004048368-A2 HETEROARYLSULFONYLMETHYL HYDROXAMIC ACIDS AND AMIDES AND THEIR USE AS PROTEASE INHIBITORS PHARMACIA CORPORATION (US) 2004-06-10 WO disclosed